This article requires a subscription to view the full text. You may purchase access to this article or login to access your subscription using the links below.
Abstract
The largest multi-omics investigation of glioblastoma to date has revealed new molecular drivers and immune subtypes of the deadly brain cancer that should inform future treatment strategies and clinical trial designs.
- ©2021 American Association for Cancer Research.
Log in using your username and password
Purchase access
You may purchase access to this article. This will require you to create an account if you don't already have one.
This OnlineFirst version was published on February 18, 2021
doi: 10.1158/2159-8290.CD-NB2021-0315
“A Complete Molecular Atlas of Glioblastoma”
Jump to section
Advertisement